ASPIRE BIOPHARMA HOLDINGS, INC. Debt Instrument, Face Amount
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Debt Instrument, Face Amount of $163.82 thousand as of 2025-12-31, per its S-1/A filed 2026-04-10.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-13
- 2025-12-31: Debt Instrument, Face Amount $163.82K.
- 2025-09-30: Debt Instrument, Face Amount $9.69M.
- 2025-02-13: Debt Instrument, Face Amount $31.25K.
- 2025-01-22: Debt Instrument, Face Amount $31.25K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2025-12-31 | $163.82K S-1/A · filed 2026-04-10 |
| 2025-09-30 | $9.69M 10-Q · filed 2025-11-14 |
| 2025-02-13 | $31.25K S-1/A · filed 2026-04-10 |
| 2025-01-22 | $31.25K S-1/A · filed 2026-04-10 |
| 2024-12-31 | $279.88K 10-Q · filed 2026-08-13 |
| 2024-12-30 | $40.63K S-1/A · filed 2026-04-10 |
| 2024-10-02 | $62.50K S-1/A · filed 2026-04-10 |
| 2024-09-27 | $1.07M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |